There is good news to look forward to with this company. The PPS has been taken to the wood shed, but we have a real therapy here and it is on the way to becoming a Billion dollar frontline treatment and possibly the future SOC.
If we had acceptable results for recurrent & refractive cancer and increased the likelihood of transplant - then we should be bullish about going to the frontline. I think we have cleared the biggest hurdle!
So the question is when are the results from frontline projected to be due?
...forth coming news includes NHL trial results, Marqibo for Melanoma, Menadione phase II results (within the next 6 mos.) and partnership/buyout. I think everyone is holding and just waiting for events to unfold.